[go: up one dir, main page]

HK1196039A - 性能增强组合物及应用方法 - Google Patents

性能增强组合物及应用方法 Download PDF

Info

Publication number
HK1196039A
HK1196039A HK14108790.9A HK14108790A HK1196039A HK 1196039 A HK1196039 A HK 1196039A HK 14108790 A HK14108790 A HK 14108790A HK 1196039 A HK1196039 A HK 1196039A
Authority
HK
Hong Kong
Prior art keywords
methods
performance enhancing
microgram
day
enhancing compositions
Prior art date
Application number
HK14108790.9A
Other languages
English (en)
Inventor
Jan Remmereit
Original Assignee
Life Science Nutrition As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Science Nutrition As filed Critical Life Science Nutrition As
Publication of HK1196039A publication Critical patent/HK1196039A/zh

Links

HK14108790.9A 2011-05-05 2012-05-04 性能增强组合物及应用方法 HK1196039A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/482,655 2011-05-05

Publications (1)

Publication Number Publication Date
HK1196039A true HK1196039A (zh) 2014-12-05

Family

ID=

Similar Documents

Publication Publication Date Title
MY159630A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
CA2818187C (en) Bromodomain inhibitors and uses thereof
CN104024227B8 (zh) 抑制脯氨酸羟化酶活性的化合物的晶型及其应用
EP3354640A3 (en) Mif inhibitors and their uses
MY164356A (en) Substituted 5-fluoro-1h-pyrazolopyridines and their use
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
WO2013066835A3 (en) Compounds and methods
WO2013179307A3 (en) Stabilized pharmaceutical compositions of saxagliptin
CN102036649A8 (zh) 精氨酸盐及其治疗口腔疾病的用途
MX340985B (es) Compuestos de n-heteroarilo.
MX2013004759A (es) Compuestos de oxima como agentes de elevacion de colesterol de lipoproteina de alta densidad (hdl).
MY156275A (en) Compositions comprising tramadol and celecoxib in the treatment of pain
EA201400537A1 (ru) 18-МЕТИЛ-6,7-МЕТИЛЕН-3-ОКСО-17-ПРЕГН-4-ЕН-21,17β-КАРБОЛАКТОНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ ЭНДОМЕТРИОЗА
EA201101214A1 (ru) Полиеновые противогрибковые композиции
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
WO2009130616A3 (en) Improved tlr3 agonist compositions
MX342947B (es) Tratamiento de diabetes tipo 2.
PH12013500371A1 (en) Therapeutic agent for pain
IN2012DN00763A (zh)
HK1201067A1 (zh) 唾液酸類似物
EP3795145A3 (en) Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dibromodulcitol
EP3456837A3 (en) Decorin compositions and use thereof
CA2834182C (en) Honey composition with l-alanyl-l-glutamine
HK1196039A (zh) 性能增强组合物及应用方法